2014 Jul 7. The Potential Therapeutic Effects of THC on Alzheimer's Disease. Cao C1, Li Y2, Liu…
Freedom WaresJuly 7, 2014
2014 Jun 18;82(6):1334-1345. doi: 10.1016/j.neuron.2014.04.039. β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition.…
Freedom WaresJune 18, 2014
2014 May 20. Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are…
Freedom WaresMay 20, 2014
Mol Med. 2014; 20(1): 29–36. Published online Mar 14, 2014. doi: 10.2119/molmed.2013.00140.revised PMCID: PMC3951462 CB2 Receptor Deficiency Increases Amyloid…
Freedom WaresMarch 14, 2014
2014 Feb 25. Endocannabinoids in Synaptic Plasticity and Neuroprotection. Xu JY1, Chen C. Author information Abstract Endocannabinoids (eCBs)…
Freedom WaresFebruary 25, 2014
2014 Feb 4. Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse…
Freedom WaresFebruary 4, 2014
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer's disease. González-Naranjo P1, Pérez-Macias N1, Campillo NE1, Pérez…
Freedom WaresJanuary 2, 2014
Endocannabinoid signalling in Alzheimer's disease. Maroof N, Pardon MC, Kendall DA. Source *Sheffield Institute for Translational Neuroscience…
Freedom WaresNovember 22, 2013
In vivo type 1 cannabinoid receptor availability in Alzheimer's disease. Ahmad R, Goffin K, Van den Stock J, De…
Freedom WaresNovember 6, 2013